MED12

MED12 encodes the Mediator complex subunit 12 protein. Also known as TRAP230 or CRSP230, it is a crucial part of the Mediator complex, which is essential for transcription regulation. MED12 acts as a bridge between transcription factors and RNA polymerase II, facilitating gene expression. It is involved in multiple signal pathways, like the Wnt pathway, influencing cell growth and differentiation.
Mutations in MED12 have been linked to various diseases, including Lujan - Fryns syndrome and some types of cancer. In drug development, targeting the Mediator complex, especially MED12, is being explored as a potential therapeutic strategy. However, due to its complex role in normal cell function, developing specific drugs remains a challenge.